Literature DB >> 10942530

Differential expression of p16(INK4a) in azoxymethane-induced mouse colon tumorigenesis.

Q S Wang1, A Papanikolaou, P R Nambiar, D W Rosenberg.   

Abstract

Alterations in the p16(INK4a) gene have been implicated in the pathogenesis of different human cancers and animal tumors. We postulated that alterations in the p16(INK4a) gene may also be involved in mouse colon tumorigenesis induced by the chemical carcinogen azoxymethane (AOM). In the present study, p16(INK4a) deletion status and its expression were examined in an AOM-induced mouse colon tumor model. Polymerase chain reaction-based deletion analysis of p16(INK4a) exon 2 showed no deletions in the colon tumors. The expression and localization of p16(INK4a) and its gene product were examined by reverse transcription-polymerase chain reaction and immunohistochemical analyses, respectively. The p16(INK4a) mRNA levels were low, and in some cases undetectable, in control colon tissue. However, colon tumors exhibited an eightfold increase in p16(INK4a) mRNA level when compared with control colon tissue (P < 0.01). Whereas control colon epithelium was uniformly negative for p16(INK4a) immunoreactivity, p16(INK4a)-immunoreactive cells were markedly increased in preneoplastic lesions and adenomas isolated from AOM-treated mice. To further examine the p16(INK4a) regulatory pathway, the retinoblastoma tumor-suppressor protein (Rb) was also examined immunohistochemically in these tissues. A heterogeneous Rb immunostaining was observed in preneoplastic lesions and adenomas. Immunohistochemical analysis also showed a reciprocal relationship between p16(INK4a) and Rb protein expression. These findings suggest that alterations in the p16(INK4a)/Rb pathway may play an important role in AOM-induced mouse colon tumorigenesis. Mol. Carcinog. 28:139-147, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942530     DOI: 10.1002/1098-2744(200007)28:3<139::aid-mc2>3.0.co;2-v

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  6 in total

1.  p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors.

Authors:  Steven L Gibson; Amelie Boquoi; Tina Chen; Norman E Sharpless; Colleen Brensinger; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2005-12-09       Impact factor: 4.742

2.  The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Authors:  K Evangelou; J Bartkova; A Kotsinas; I S Pateras; M Liontos; G Velimezi; M Kosar; T Liloglou; I P Trougakos; L Dyrskjot; C L Andersen; M Papaioannou; Y Drosos; G Papafotiou; Z Hodny; B Sosa-Pineda; X-R Wu; A Klinakis; T Ørntoft; J Lukas; J Bartek; V G Gorgoulis
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

Review 3.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

4.  INK4a-ARF alterations in liver cell adenoma.

Authors:  A Tannapfel; C Busse; F Geissler; H Witzigmann; J Hauss; C Wittekind
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

5.  Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon.

Authors:  Praveen Rajendran; Wan-Mohaiza Dashwood; Li Li; Yuki Kang; Eunah Kim; Gavin Johnson; Kay A Fischer; Christiane V Löhr; David E Williams; Emily Ho; Masayuki Yamamoto; David A Lieberman; Roderick H Dashwood
Journal:  Clin Epigenetics       Date:  2015-09-18       Impact factor: 6.551

6.  Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice.

Authors:  Laura M Beaver; Christiane V Lӧhr; John D Clarke; Sarah T Glasser; Greg W Watson; Carmen P Wong; Zhenzhen Zhang; David E Williams; Roderick H Dashwood; Jackilen Shannon; Philippe Thuillier; Emily Ho
Journal:  Curr Dev Nutr       Date:  2017-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.